Matthew Igbinigie

Matthew Igbinigie

Auto-generated profile, based on publicly available information

Matthew Igbinigie

Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch, Galveston, Texas

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2018 in JBJS Case Connector
Verified
Journal Article
Closed access
BGBarkha Gurbani
Barkha Gurbani
MIMatthew Igbinigie
Matthew Igbinigie
AKAristides Koutrouvelis
Aristides Koutrouvelis
JAJack B. Alperin
Jack B. Alperin
RLRonald W. Lindsey
Ronald W. Lindsey
Case: A 29-year-old man with mild hemophilia A and Ollier disease presented with bilateral atraumatic forearm pseudotumors. Both forearm pseudotumors were successfully treated surgically with staged radical extirpation and factor VIII replacement therapy. Conclusion: Pseudotumors typically occur in adolescents with severe, poorly controlled hemophilia A. The development of factor VIII replacement therapy has progressively reduced the incidence of pseudotumors in patients in the developed world. No standardized therapy exists for pseudotumors that continue to bleed into the muscles despite nonoperative measures. Persistent masses require surgical removal with careful preoperative planning and a team approach.

1 January 2019 in JBJS Case Connector
Verified
Journal Article
Closed access
KAKessiena L. Aya
Kessiena L. Aya
KCKelly D. Carmichael
Kelly D. Carmichael
MIMatthew Igbinigie
Matthew Igbinigie
Case: We present an unusual case of a distal metaphyseal femur insufficiency fracture in an adolescent with a history of multiple low-energy appendicular fractures. A genetic workup was significant for a variant of unknown significance to the Col1A1 gene. Conclusions: To our knowledge, this is the first report of this collagen gene variant as a risk factor for multiple fractures. The case illustrates the presentation of this gene’s phenotype and suggested medical management.